GoodRx (GDRX) News Today $4.81 -0.05 (-1.03%) Closing price 04:00 PM EasternExtended Trading$4.86 +0.06 (+1.14%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period GoodRx (GDRX) to Release Quarterly Earnings on ThursdayGoodRx (NASDAQ:GDRX) will be releasing earnings before the market opens on Thursday, February 27. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=661075)February 20 at 3:08 AM | marketbeat.comGoodRx Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity ThreatsFebruary 19 at 5:40 AM | finance.yahoo.com1 Healthcare Stock Primed for Growth and 2 to SnubFebruary 17, 2025 | finance.yahoo.comIMC Chicago LLC Makes New Investment in GoodRx Holdings, Inc. (NASDAQ:GDRX)IMC Chicago LLC bought a new position in GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 65,315 shares of the company's stock, valued at approximately $304,000. Other hedge funds haFebruary 13, 2025 | marketbeat.comGoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesGoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the fifteen analysts that are currently covering the firm, MarketBeat reports. Five analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has giveFebruary 10, 2025 | marketbeat.comGoodRx names Christopher A. McGinnis as CFOFebruary 6, 2025 | markets.businessinsider.comGoodRx Appoints Christopher A. McGinnis as Chief Financial OfficerFebruary 5, 2025 | businesswire.comGoodRx's SWOT analysis: stock faces headwinds but growth potential remainsFebruary 3, 2025 | msn.comGoodRx (NASDAQ:GDRX) Shares Gap Down - Time to Sell?GoodRx (NASDAQ:GDRX) Shares Gap Down - Should You Sell?January 31, 2025 | marketbeat.comGoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference CallJanuary 30, 2025 | businesswire.comTD Cowen Sticks to Its Buy Rating for GoodRx Holdings (GDRX)January 29, 2025 | markets.businessinsider.comIs GoodRx Holdings (GDRX) the Best Affordable Stock Under $5 to Buy Now?January 27, 2025 | msn.comAssenagon Asset Management S.A. Trims Position in GoodRx Holdings, Inc. (NASDAQ:GDRX)Assenagon Asset Management S.A. lowered its holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) by 16.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 323,376 shares of the company's stock aJanuary 24, 2025 | marketbeat.comGoodRx appoints Scott Wagner as new board directorJanuary 23, 2025 | msn.comScott Wagner appointed Co-Chair of GoodRx BoardJanuary 22, 2025 | msn.comScott Wagner Joins GoodRx Board of DirectorsJanuary 22, 2025 | businesswire.comGoodRx Holdings, Inc. (NASDAQ:GDRX) Sees Large Drop in Short InterestGoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) saw a significant drop in short interest in December. As of December 31st, there was short interest totalling 7,470,000 shares, a drop of 5.8% from the December 15th total of 7,930,000 shares. Approximately 8.6% of the company's stock are short sold. Based on an average daily volume of 1,370,000 shares, the days-to-cover ratio is currently 5.5 days.January 19, 2025 | marketbeat.comGoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Consensus Recommendation of "Moderate Buy" from AnalystsGoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the fifteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold recommendation, nine have given a buJanuary 16, 2025 | marketbeat.comGoodRx Holdings: Strong Business Fundamentals and Undervalued Potential Justify Buy Rating Despite CFO TransitionJanuary 15, 2025 | markets.businessinsider.comBarclays PLC Grows Position in GoodRx Holdings, Inc. (NASDAQ:GDRX)Barclays PLC boosted its holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) by 1,316.1% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 140,113 shares of the company's stock after buying an additional 130,219 shares during the period. BarclaysJanuary 15, 2025 | marketbeat.comGoodRx stock falls on CFO resignation newsJanuary 14, 2025 | in.investing.comGoodRx appoints interim CFO as Karsten Voermann resignsJanuary 14, 2025 | markets.businessinsider.comGoodRx price target lowered to $4.25 from $4.50 at BofAJanuary 14, 2025 | markets.businessinsider.comGoodRx CFO Karsten Voermann to Resign for Personal ReasonsJanuary 13, 2025 | pymnts.comGoodRx (NASDAQ:GDRX) Trading Down 8.4% Following Analyst DowngradeGoodRx (NASDAQ:GDRX) Shares Down 8.4% Following Analyst DowngradeJanuary 13, 2025 | marketbeat.comGoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by WildfiresJanuary 12, 2025 | finance.yahoo.comCitigroup Has Lowered Expectations for GoodRx (NASDAQ:GDRX) Stock PriceCitigroup lowered their price objective on shares of GoodRx from $7.00 to $6.25 and set a "buy" rating on the stock in a research note on Friday.January 10, 2025 | marketbeat.comGoodRx (NASDAQ:GDRX) Shares Up 5.8% - What's Next?GoodRx (NASDAQ:GDRX) Shares Up 5.8% - Here's What HappenedJanuary 10, 2025 | marketbeat.comGoodRx price target lowered to $6 from $7 at KeyBancJanuary 8, 2025 | markets.businessinsider.comAssessing GoodRx Holdings: Insights From 4 Financial AnalystsJanuary 8, 2025 | benzinga.comGoodRx (NASDAQ:GDRX) Price Target Lowered to $6.00 at KeyCorpKeyCorp dropped their price target on GoodRx from $7.00 to $6.00 and set an "overweight" rating for the company in a research report on Wednesday.January 8, 2025 | marketbeat.comGoodRx: A Business In Transition, But It Has Likely Reached Its Low (Rating Upgrade)January 8, 2025 | seekingalpha.comGoodRx (NASDAQ:GDRX) Sees Strong Trading Volume - Here's WhyGoodRx (NASDAQ:GDRX) Sees Unusually-High Trading Volume - Here's WhyJanuary 3, 2025 | marketbeat.comGoodRx Holdings, Inc. (NASDAQ:GDRX) Short Interest UpdateGoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) saw a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 7,930,000 shares, an increase of 6.6% from the November 30th total of 7,440,000 shares. Based on an average trading volume of 1,350,000 shares, the short-interest ratio is currently 5.9 days. Currently, 9.1% of the shares of the company are short sold.January 2, 2025 | marketbeat.comBarclays PLC Has $973,000 Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX)Barclays PLC grew its position in GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) by 1,316.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 140,113 shares of the company's stock after purchasing an additional 130,2December 31, 2024 | marketbeat.comState Street Corp Decreases Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX)State Street Corp lessened its position in GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) by 23.6% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 849,470 shares of the company's stock after selling 262,02December 29, 2024 | marketbeat.comGoodRx (NASDAQ:GDRX) Trading Up 2% - Still a Buy?GoodRx (NASDAQ:GDRX) Trading Up 2% - Still a Buy?December 27, 2024 | marketbeat.comRaymond James adds UnitedHealth to Analyst Current Favorites list, cuts GoodRxDecember 26, 2024 | markets.businessinsider.comFranklin Resources Inc. Takes Position in GoodRx Holdings, Inc. (NASDAQ:GDRX)Franklin Resources Inc. acquired a new position in GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 821,233 shares of the company'December 24, 2024 | marketbeat.comGoodRx Holdings, Inc. (NASDAQ:GDRX) Given Average Rating of "Moderate Buy" by BrokeragesShares of GoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) have received an average recommendation of "Moderate Buy" from the sixteen ratings firms that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, five have assigDecember 22, 2024 | marketbeat.comGoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 18, 2024 | businesswire.comGoodRx Holdings: Buy Rating Reaffirmed Amid Leadership Stability and Growth ProspectsDecember 18, 2024 | markets.businessinsider.comGoodRx names new CEODecember 17, 2024 | bizjournals.comGoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. CountiesDecember 17, 2024 | stockhouse.comGoodRx price target lowered to $6 from $7 at Morgan StanleyDecember 17, 2024 | markets.businessinsider.comMorgan Stanley Sticks to Their Hold Rating for GoodRx Holdings (GDRX)December 17, 2024 | markets.businessinsider.comMorgan Stanley Cuts GoodRx (NASDAQ:GDRX) Price Target to $6.00Morgan Stanley decreased their target price on GoodRx from $7.00 to $6.00 and set an "equal weight" rating on the stock in a research report on Tuesday.December 17, 2024 | marketbeat.comGoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive OfficerDecember 16, 2024 | businesswire.comFortem Financial Group LLC Buys New Shares in GoodRx Holdings, Inc. (NASDAQ:GDRX)Fortem Financial Group LLC purchased a new position in GoodRx Holdings, Inc. (NASDAQ:GDRX - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 111,183 shares of the company's stock, valued at approximatDecember 11, 2024 | marketbeat.comIs GoodRx Holdings (GDRX) the Best NASDAQ Penny Stock to Buy Right Now?December 11, 2024 | insidermonkey.com Get GoodRx News Delivered to You Automatically Sign up to receive the latest news and ratings for GDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address GDRX Media Mentions By Week GDRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GDRX News Sentiment▼0.250.60▲Average Medical News Sentiment GDRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GDRX Articles This Week▼37▲GDRX Articles Average Week Get GoodRx News Delivered to You Automatically Sign up to receive the latest news and ratings for GDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies WillScot Mobile Mini News Today Etsy News Today MARA News Today Lyft News Today QXO News Today Remitly Global News Today Amentum News Today Frontdoor News Today CarGurus News Today DLocal News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GDRX) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GoodRx Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GoodRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
